Optical Correction and Visual Functions of Adults With Amblyopia
Amblyopia is a developmental anomaly resulting from abnormal visual experiences in early life. Amblyopia causes reduced visual acuity in the absence of a pathology. Adult sensory systems are believed to be structurally invariant beyond early, critical periods of development. However, recent evidence suggest that visual
| Condition(s) | Amblyopia |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | Amblyopia is a developmental anomaly resulting from abnormal visual experiences in early life. Amblyopia causes reduced visual acuity in the absence of a pathology. Adult sensory systems are believed to be structurally invariant beyond early, critical periods of development. However, recent evidence suggest that visual functions in adults with amblyopia can be improved with optical correction alone. This study aims to investigate whether improvements in best corrected visual acuity and other visual functions can result following appropriate optical correction in adults with amblyopia. Functional measures relating to vision, binocular vision, and eye movements will be used to assess the efficacy of refractive correction for improving vision. This study will help us better understand the imp |
| Who can participate | Inclusion Criteria: * 18-39 (inclusive) years of age * Anisometropic amblyopia (difference of ≥0.50D spherical equivalent or ≥1.50D astigmatism between eyes) or mixed mechanism amblyopia (strabismus and anisometropia) * Best corrected visual acuity (BCVA) in the amblyopic eye of 0.3 logMAR to 1.0 logMAR (inclusive) * BCVA in the non-amblyopic eye of 0.1 logMAR or better, and an interocular VA difference of 2 logMAR lines or more * Difference of 1.00D or more between current refractive correction and study prescription * Good general health Exclusion Criteria: * Other pathological ocular anomalies known to cause reduced visual acuity * Presbyopia (based on amplitude of accommodation) * Inability to tolerate prescribed refractive correction in spectacles (e.g., due to aniseikonia) * Contrain |
| Ages | 18 Years to 39 Years |
| Sex | All |
| Accepts healthy volunteers | Yes |
| Lead sponsor | Centre for Eye and Vision Research |
| Locations | Waterloo, Ontario, Canada; Hong Kong, Guangdong, Hong Kong |
| Start date | 2022-06-13 |
| NCT ID | NCT05394987 |
| Official listing | https://clinicaltrials.gov/study/NCT05394987 |